Resources

This reports updates a literature review that looked at international and Australian clinical, academic and policy journals, as well as media articles or sources in relation to biosimilar medicines, to help inform policy development and communication activities. It covers December 2016 to March 2017

The Australian Government and state and territory governments’ collective response to PricewaterhouseCoopers’ analysis of the Australian Eye and Tissue Sector (2015).

This poster shows how your body starts repairing once you stop smoking.

This poster shows how your body starts repairing once you stop smoking.

The Health Portfolio Budget Statements for the 2017 to 2018 financial year outline how the Government has allocated resources to outcomes for all entities within our portfolio.

We commissioned this 2017 evaluation of the Australian Government’s Rheumatic Fever Strategy (RFS). The findings informed the Australian Government’s decisions on the continued funding and expansion of the RFS, announced through the 2017–18 Budget.

This agreement between the Australian Government and the AMA sets out their shared principles and vision for a stronger health care system in Australia and their intended actions.

This agreement between the Australian Government and the RACGP sets out their shared principles and vision for a stronger Medicare and health system and their intended actions.

This document summarises the Medicare Benefits Schedule (MBS) Review Taskforce’s recommendations in response to the Thoracic Medicine Clinical Committee report.

BreastScreen Australia services and State Coordination Units (SCUs) use this form to respond to the Data Assessor’s report and any comments made by the assessor.

Data Assessors use this form to record their accreditation survey findings from undertaking a Data Governance and Management Assessment (DGMA) of a BreastScreen Australia Service or State Coordination Unit (SCU).

This document summarises the Medicare Benefits Schedule (MBS) Review Taskforce’s recommendations in response to the Ear, Nose and Throat Surgery Clinical Committee report.

This document summarises the Medicare Benefits Schedule (MBS) Review Taskforce’s recommendations in response to the Gastroenterology Clinical Committee report.

This document summarises the Medicare Benefits Schedule (MBS) Review Taskforce’s recommendations in response to the Principles and Rules report.

We want to work effectively with our stakeholders — to listen, learn and continue to improve our performance. To do this we use 5 principles to help our engagement. We are purposeful, inclusive, timely, transparent and respectful.

Australian Government response to House of Representatives Standing Committee on Health report: Skin cancer in Australia – our national cancer

A summary of the major items discussed at the second MDAF meeting.

This campaign evaluation report outlines the results of a survey done to understand and estimate the reach and effectiveness of the third phase of the BreastScreen Australia campaign.

This report from Deloitte looks at the role of the National Mental Health Commission and explores ways it could be improved.

This report contains the recommendations the Pathology Clinical Committee made to the MBS Review Taskforce about tissue (anatomical) pathology/cytology items, after public consultation.

This document summarises the Medicare Benefits Schedule (MBS) Review Taskforce’s recommendations in response to the Obstetrics Clinical Committee report.

This report contains final analytical data sets representing food from contaminated areas for use in dietary exposure calculations.

This summary report provides a high level overview of the Perfluorinated chemicals in food – dietary exposure assessment.

This document outlines recommendations for other controls for perfluorinated chemicals in Australia.